Mark Abdelmalek, MD
MOHS-Micrographic Surgery · Philadelphia, PANPI 1972543155
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Kerecis Limited accounts for 64.4% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $195, 8.8 times the $22 reported in 2020. That places this record below the midpoint for mohs-micrographic surgery clinicians in PA, where the typical reported total is $1,161.
Across 12 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$172
- AbbVie$51
- Nevro Corp.$22
- Novartis$22
What the payments were for
- Food & beverage$266100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 7 | $172 |
| AbbVie | 3 | $51 |
| Nevro Corp. | 1 | $22 |
| Novartis | 1 | $22 |
How this compares
$266 in reported general payments places this provider in the 15th percentile of 48 mohs-micrographic surgery providers in Pennsylvania.
See all mohs-micrographic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 32 | $1,760 |
| Mupirocin | 133 | $890 |
| Cefadroxil | 120 | $770 |
| Triamcinolone Acetonide | 77 | $666 |
| Cephalexin | 57 | $646 |
| Ketoconazole | 28 | $590 |
| Tretinoin | 13 | $562 |
| Doxycycline Hyclate | 52 | $335 |
| Hydrocortisone | 64 | $332 |
| Fluocinonide | 19 | $321 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $47 |
| Amoxicillin | 23 | $42 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Philadelphia
- Jason SchoenfeldPhiladelphia$20K
- Ernest BenedettoPhiladelphia$9K
- Thomas ReganPhiladelphia$927
- Abhishek AphalePhiladelphia$295
- Gregory FulchieroAltoona$24K
- Cynthia BartusAllentown$10K
- Carmen CampanelliYardley$8K
- Aradhna SaxenaFort Washington$8K
- Nicole VelezCranberry Township$6K
- Justin VujevichPittsburgh$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.